glp-1 cardiovascular outcomes trial results august 2025 Can Dual Incretin Receptor Agonists Exert Better Protection than Selective Receptor Agonists? Highlights from SURPASS-CVOT | Diabetes Therapy Emerging Frontiers in GLP-1 Therapeutics:

It is important to emphasise that there is no officially confirmed causal link between retatrutide and all reported skin effects at this stage

These findings are further supported by retrospective data from Sharpe et al (2019) and several case series, which consistently reported no significant increase in miscarriage, preterm birth, or CA

This free calorie and macro calculator is provided for educational purposes and does not replace medical advice The Calorie & Macro Calculator is used as part of a comprehensive weight management strategy to help patients: The calculator estimates: These values are based on widely accepted metabolic equations and activity multipliers commonly used in medical and bariatric practices

Be sure to wash the backs of your hands, between your fingers, and under your fingernails

This approach allows researchers to detect potential safety signals that may deserve further clinical investigation